Send to

Choose Destination
Pain. 2017 Sep;158(9):1792-1801. doi: 10.1097/j.pain.0000000000000982.

Spinal microglia are required for long-term maintenance of neuropathic pain.

Author information

aThe Alan Edwards Centre for Research on Pain, McGill University, Montreal, QC, Canada bDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada cFaculty of Dentistry, McGill University, Montreal, QC, Canada dInstitut universitaire en santé mentale de Québec, QC, Canada eDepartment of Psychiatry and Neuroscience, Université Laval, Québec, QC, Canada.


While spinal microglia play a role in early stages of neuropathic pain etiology, whether they are useful targets to reverse chronic pain at late stages remains unknown. Here, we show that microglia activation in the spinal cord persists for >3 months following nerve injury in rodents, beyond involvement of proinflammatory cytokine and chemokine signalling. In this chronic phase, selective depletion of spinal microglia in male rats with the targeted immunotoxin Mac1-saporin and blockade of brain-derived neurotrophic factor-TrkB signalling with intrathecal TrkB Fc chimera, but not cytokine inhibition, almost completely reversed pain hypersensitivity. By contrast, local spinal administration of Mac1-saporin did not affect nociceptive withdrawal threshold in control animals nor did it affect the strength of afferent-evoked synaptic activity in the spinal dorsal horn in normal conditions. These findings show that the long-term, chronic phase of nerve injury-induced pain hypersensitivity is maintained by microglia-neuron interactions. The findings also effectively separate the central signalling pathways underlying the maintenance phase of the pathology from the early and peripheral inflammatory reactions to injury, pointing to different targets for the treatment of acute vs chronic injury-induced pain.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center